245 related articles for article (PubMed ID: 33208092)
1. Addition of routine blood biomarkers to TIMI risk score improves predictive performance of 1-year mortality in patients with ST-segment elevation myocardial infarction.
Oh PC; Eom YS; Moon J; Jang HJ; Kim TH; Suh J; Kong MG; Park SD; Kwon SW; Suh SY; Lee K; Han SH; Ahn T; Kang WC
BMC Cardiovasc Disord; 2020 Nov; 20(1):486. PubMed ID: 33208092
[TBL] [Abstract][Full Text] [Related]
2. Association of serum transaminases with short- and long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Gao M; Cheng Y; Zheng Y; Zhang W; Wang L; Qin L
BMC Cardiovasc Disord; 2017 Jan; 17(1):43. PubMed ID: 28129742
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Impact of Combined Dysglycemia and Hypoxic Liver Injury on Admission in Patients With ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Coronary Intervention (from the INTERSTELLAR Cohort).
Jang HJ; Oh PC; Moon J; Suh J; Park HW; Park SD; Lee K; Kim JS; Lee HJ; Choi RK; Choi YJ; Kang WC; Kwon SW; Kim TH
Am J Cardiol; 2017 Apr; 119(8):1179-1185. PubMed ID: 28214004
[TBL] [Abstract][Full Text] [Related]
4. Elevated serum uric acid is associated with a greater inflammatory response and with short- and long-term mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Mandurino-Mirizzi A; Cornara S; Somaschini A; Demarchi A; Galazzi M; Puccio S; Montalto C; Crimi G; Ferlini M; Camporotondo R; Gnecchi M; Ferrario M; Oltrona-Visconti L; De Ferrari GM
Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):608-614. PubMed ID: 33358717
[TBL] [Abstract][Full Text] [Related]
5. Correlation and prognostic role of neutrophil to lymphocyte ratio and SYNTAX score in patients with acute myocardial infarction treated with percutaneous coronary intervention: A six-year experience.
Zuin M; Rigatelli G; Picariello C; dell'Avvocata F; Marcantoni L; Pastore G; Carraro M; Nanjundappa A; Faggian G; Roncon L
Cardiovasc Revasc Med; 2017 Dec; 18(8):565-571. PubMed ID: 28529092
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of triglyceride glucose index combined with neutrophil-to-lymphocyte ratio for major adverse cardiac events after PCI for acute ST-segment elevation myocardial infarction.
Wang L; Wang Y; Wang W; Wang Z
Sci Rep; 2024 Jun; 14(1):12634. PubMed ID: 38824158
[TBL] [Abstract][Full Text] [Related]
7. Plaque characteristics and inflammatory markers for the prediction of major cardiovascular events in patients with ST-segment elevation myocardial infarction.
Her AY; Cho KI; Singh GB; An DS; Jeong YH; Koo BK; Shin ES
Int J Cardiovasc Imaging; 2017 Oct; 33(10):1445-1454. PubMed ID: 28555389
[TBL] [Abstract][Full Text] [Related]
8. Comparison of neutrophil-to-lymphocyte ratio and mean platelet volume in the prediction of adverse events after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction.
Machado GP; Araujo GN; Carpes CK; Lech M; Mariani S; Valle FH; Bergoli LCC; Gonçalves SC; Wainstein RV; Wainstein MV
Atherosclerosis; 2018 Jul; 274():212-217. PubMed ID: 29803159
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of neutrophil to lymphocyte ratio in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention: a meta-analysis.
Zhang S; Diao J; Qi C; Jin J; Li L; Gao X; Gong L; Wu W
BMC Cardiovasc Disord; 2018 May; 18(1):75. PubMed ID: 29716535
[TBL] [Abstract][Full Text] [Related]
10. Discharge Hemoglobin Association with Long-Term Outcomes of ST-Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention.
Gao M; Zhang X; Qin L; Zheng Y; Zhang Z; Tong Q; Li H
Cardiovasc Ther; 2020; 2020():8647837. PubMed ID: 32190122
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of prepercutaneous coronary intervention TIMI flow in patients with ST-segment and non-ST-segment elevation myocardial infarction: Results from the FAST-MI 2010 registry.
Bailleul C; Aissaoui N; Cayla G; Dillinger JG; Jouve B; Schiele F; Ferrières J; Simon T; Danchin N; Puymirat E;
Arch Cardiovasc Dis; 2018 Feb; 111(2):101-108. PubMed ID: 28939193
[TBL] [Abstract][Full Text] [Related]
12. Association of Anemia With Outcomes Among ST-Segment-Elevation Myocardial Infarction Patients Receiving Primary Percutaneous Coronary Intervention.
Moghaddam N; Wong GC; Cairns JA; Goodman SG; Perry-Arnesen M; Tocher W; Mackay M; Singer J; Lee T; Rao SV; Fordyce CB
Circ Cardiovasc Interv; 2018 Dec; 11(12):e007175. PubMed ID: 30562086
[TBL] [Abstract][Full Text] [Related]
13. Relationship of Platelet Reactivity and Inflammatory Markers to Recurrent Adverse Events in Patients with ST-Elevation Myocardial Infarction.
Adatia K; Farag MF; Gue YX; Srinivasan M; Gorog DA
Thromb Haemost; 2019 Nov; 119(11):1785-1794. PubMed ID: 31437861
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of MELD-XI in elderly patients with ST-segment elevation myocardial infarction: an observational study.
He SJ; Weng JX; Chen HJ; Li HQ; Guo WQ; Cao Q; Xu S; Yan HB; Peng CN
BMC Cardiovasc Disord; 2021 Jan; 21(1):53. PubMed ID: 33509076
[TBL] [Abstract][Full Text] [Related]
15. The combination of neutrophil-to-lymphocyte ratio and platelet correlation parameters in predicting the no-reflow phenomenon after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
Zhang Q; Hu M; Sun J; Ma S
Scand Cardiovasc J; 2020 Dec; 54(6):352-357. PubMed ID: 32597237
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of neutrophil gelatinase-associated lipocalin and cystatin C as biomarkers of acute kidney injury after ST-segment elevation myocardial infarction treated by percutaneous coronary intervention.
Nguyen LS; Spagnoli V; Kerneis M; Hauguel-Moreau M; Barthélémy O; Collet JP; Montalescot G; Silvain J
Arch Cardiovasc Dis; 2019 Mar; 112(3):180-186. PubMed ID: 30639197
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of neutrophil to lymphocyte ratio in long-term outcomes of left main and/or three-vessel disease in patients with acute myocardial infarction.
Xu N; Tang XF; Yao Y; Zhao X; Chen J; Gao Z; Yang Y; Gao RL; Xu B; Yuan JQ
Catheter Cardiovasc Interv; 2018 Feb; 91(S1):551-557. PubMed ID: 29330938
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Celık T; Balta S; Demır M; Yıldırım AO; Kaya MG; Ozturk C; Demırkol S; Unlu M; Kılıc S; Aydın İ; Iyısoy A
Cardiol J; 2016; 23(1):84-92. PubMed ID: 26503078
[TBL] [Abstract][Full Text] [Related]
19. High cystatin C levels predict long-term mortality in patients with ST-segment elevation myocardial infarction undergoing late percutaneous coronary intervention: A retrospective study.
Chen Y; Fan Y; Men M; Shen G; Ma A
Clin Cardiol; 2019 May; 42(5):572-578. PubMed ID: 30907012
[TBL] [Abstract][Full Text] [Related]
20. Predictors of mortality in patients with non-anterior ST-segment elevation myocardial infarction: Analysis from the HORIZONS-AMI trial.
Huang X; Redfors B; Chen S; Gersh BJ; Mehran R; Zhang Y; McAndrew T; Ben-Yehuda O; Mintz GS; Stone GW
Catheter Cardiovasc Interv; 2019 Aug; 94(2):172-180. PubMed ID: 30690854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]